Abstract:In response to T-dependent Ag, germinal centers (GC) generate bone marrow-resident plasma cells (BMPC) and memory B cells (MBC). In this study, we demonstrate that the bone morphogenetic protein receptor 1A (BMPR1A) signaling pathway, which regulates differentiation and self-renewal in multiple stem cell populations, regulates GC dynamics and resultant establishment of BMPC and MBC. Expression studies using quantitative PCR and novel Bmpr1a.IRES.EGFP reporter mice demonstrated that Bmpr1a expression is upregul… Show more
“…In addition to changes in X-linked gene expression, we identified autosomal transcriptional changes in Xist cKO B cells with SLE phenotypes. In CD11c+ ABCs from Xist cKO High mice, upregulated autosomal genes were enriched for genes involved in lymphocyte activation, including Bcl3 (important for antigen-specific autoantibody formation) 73 , Bmpr1a (upregulated in some memory B cell subsets) 74 , Cxcr4 (plays a role in B cell homeostasis and trafficking) 75 , and Fas (upregulated in ABCs from patients with SLE) 41 . In CD11c+ ABCs from pristane-treated Xist cKO mice, upregulated autosomal genes were enriched for genes involved in immune processes, including Pik3r6 (mediates signaling pathways that regulate proliferation, class-switch recombination, and plasma cell differentiation) 76 , Sh3kbp1 (poises B cells to respond to BCR stimulation) 77 , and Zbtb20 (involved in plasma cell differentiation via Irf4) 78 .…”
Systemic lupus erythematosus (SLE) is an autoimmune disease preferentially observed in females. X-linked gene expression in XX females is normalized to that of XY males by X-Chromosome Inactivation (XCI). However, B cells from female SLE patients and mouse models of SLE exhibit mislocalization of Xist RNA, a critical regulator of XCI, and aberrant expression of X-linked genes, suggesting that impairment of XCI may contribute to disease. Here, we find that a subset of female mice harboring a conditional deletion of Xist in B cells ('Xist cKO') spontaneously develop SLE phenotypes, including expanded activated B cell subsets, disease-specific autoantibodies, and glomerulonephritis. Moreover, pristane-induced SLE-like disease is more severe in Xist cKO mice. Activated B cells from Xist cKO mice with SLE phenotypes have increased expression of proinflammatory X-linked genes implicated in SLE. Together, this work indicates that impaired XCI maintenance in B cells directly contributes to the female-bias of SLE.
“…In addition to changes in X-linked gene expression, we identified autosomal transcriptional changes in Xist cKO B cells with SLE phenotypes. In CD11c+ ABCs from Xist cKO High mice, upregulated autosomal genes were enriched for genes involved in lymphocyte activation, including Bcl3 (important for antigen-specific autoantibody formation) 73 , Bmpr1a (upregulated in some memory B cell subsets) 74 , Cxcr4 (plays a role in B cell homeostasis and trafficking) 75 , and Fas (upregulated in ABCs from patients with SLE) 41 . In CD11c+ ABCs from pristane-treated Xist cKO mice, upregulated autosomal genes were enriched for genes involved in immune processes, including Pik3r6 (mediates signaling pathways that regulate proliferation, class-switch recombination, and plasma cell differentiation) 76 , Sh3kbp1 (poises B cells to respond to BCR stimulation) 77 , and Zbtb20 (involved in plasma cell differentiation via Irf4) 78 .…”
Systemic lupus erythematosus (SLE) is an autoimmune disease preferentially observed in females. X-linked gene expression in XX females is normalized to that of XY males by X-Chromosome Inactivation (XCI). However, B cells from female SLE patients and mouse models of SLE exhibit mislocalization of Xist RNA, a critical regulator of XCI, and aberrant expression of X-linked genes, suggesting that impairment of XCI may contribute to disease. Here, we find that a subset of female mice harboring a conditional deletion of Xist in B cells ('Xist cKO') spontaneously develop SLE phenotypes, including expanded activated B cell subsets, disease-specific autoantibodies, and glomerulonephritis. Moreover, pristane-induced SLE-like disease is more severe in Xist cKO mice. Activated B cells from Xist cKO mice with SLE phenotypes have increased expression of proinflammatory X-linked genes implicated in SLE. Together, this work indicates that impaired XCI maintenance in B cells directly contributes to the female-bias of SLE.
“…The BMPR-IA signaling pathway regulates differentiation and self-renewal in several stem-cell populations in the germinal center. Mouse germinal-center B cells showed increased expression of BMPR-IA, and the targeted deletion of BMPR-IA impaired the germinal-center reaction and reduced differentiation from plasmablasts to antibody-producing plasma cells ( 161 ). One study identified that although human germinal-center B cells express high levels of BMPRI and low levels of BMPRII, naïve B cells show low levels of BMPRI and high levels of BMPRII ( 162 ).…”
Section: Interactions Of Bmps Activins and Gdfs With The Adaptive Imm...mentioning
The TGF-β superfamily is a group of secreted polypeptides with key roles in exerting and regulating a variety of physiologic effects, especially those related to cell signaling, growth, development, and differentiation. Although its central member, TGF-β, has been extensively reviewed, other members of the family—namely bone morphogenetic proteins (BMPs), activins, and growth and differentiation factors (GDFs)—have not been as thoroughly investigated. Moreover, although the specific roles of TGF-β signaling in cancer immunology and immunotherapy resistance have been extensively reported, little is known of the roles of BMPs, activins, and GDFs in these domains. This review focuses on how these superfamily members influence key immune cells in cancer progression and resistance to treatment.
Summary
Immunological memory is a composite of lasting antibody titers maintained by plasma cells in conjunction with memory T and B cells. Memory B cells are a critical reservoir for plasma cell generation in the secondary response. Identification of memory B cells requires that they be distinguished from naïve, activated, and germinal center precursors and from plasma cells. Memory B cells are heterogeneous in isotype usage, immunoglobulin mutational content, and phenotypic marker expression. Phenotypic subsets of memory B cells are defined by PD‐L2, CD80, and CD73 expression in mice, by CD27 and FCRL4 expression in humans and by T‐bet in both mice and humans. These subsets display marked functional heterogeneity, including the ability to rapidly differentiate into plasma cells versus seed germinal centers in the secondary response. Memory B cells are located in the spleen, blood, other lymphoid organs, and barrier tissues, and recent evidence indicates that some memory B cells may be dedicated tissue‐resident populations. Open questions about memory B cell longevity, renewal and progenitor‐successor relationships with plasma cells are discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.